(1) Chandana, J., KUMAR, G. A., Vaishnavi, B., Adarsh, A., Rao, T. R., & Rajesham, V. (2024). In-vitro antioxidant and antidiabetic activity of Crinum latifolium. World Journal of Biology Pharmacy and Health Sciences, 19(3), 295–303. https://doi.org/10.30574/wjbphs.2024.19.3.0319
(2) Crinum latifolium L. | Plants of the World Online | Kew Science. (2020). Plants of the World Online. https://powo.science.kew.org/taxon/urn%3Alsid%3Aipni.org%3Anames%3A63951-1
(3) Gasca-Silva, C. A., Gomes, J. V. D., Gomes-Copeland, K. K. P., Fonseca-Bazzo, Y. M., Fagg, C. W., & Silveira, D. (2022). Recent updates on Crinum latifolium L. (Amaryllidaceae): A review of ethnobotanical, phytochemical, and biological properties. South African Journal of Botany, 146, 162–173. https://doi.org/10.1016/j.sajb.2021.10.021
(4) Human Foods Program. (2025). Letter to the Dietary Supplement Industry on the DSHEA Disclaimer. U.S. Food and Drug Administration. https://www.fda.gov/food/information-industry-dietary-supplements/letter-dietary-supplement-industry-dshea-disclaimer
(5) Nguyen, H.-Y. T., Vo, B.-H. T., Nguyen, L.-T. H., Bernad, J., Alaeddine, M., Coste, A., Reybier, K., Pipy, B., & Nepveu, F. (2013). Extracts of Crinum latifolium inhibit the cell viability of mouse lymph oma cell line EL4 and induce activation of anti-tumour activity of macrophages in vitro. Journal of Ethnopharmacology, 149(1), 75–83. https://doi.org/10.1016/j.jep.2013.06.002
(6) Wisuwat T., Tamonwan U., Pithi C., Supaporn P., Todsaphol C., Pakakrong K., Pasarapa T., & Suchada S. (2022). Standardization of the ethanolic extract of Crinum latifolium leaves by two bioactive markers with antiproliferative activity against TGF-β-promoted prostate stromal cells (WPMY-1). BMC Complementary Medicine and Therapies, 22(1). https://doi.org/10.1186/s12906-022-03617-x
(7) Zvetkova, E., Wirleitner, B., Tram, N. T., Schennach, H., & Fuchs, D. (2001). Aqueous extracts of Crinum latifolium (L.) and Camellia sinensis show immunomodulatory properties in human peripheral blood mononuclear cells. International immunopharmacology, 1(12), 2143–2150. https://doi.org/10.1016/s1567-5769(01)00140-0